Valganciclovir hydrochloride for Oral
NDC 0591-2579, Valganciclovir hydrochloride, powder, for solution, from Actavis Pharma, Inc..
- Product NDC
- 0591-2579
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205220
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2579 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VALGANCICLOVIR HYDROCHLORIDE50 mg/mL
Pharmacologic classes
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; DNA Polymerase Inhibitors [MoA]; Nucleoside Analog Antiviral [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-2579-20 | 00591257920 | 100 mL in 1 BOTTLE, GLASS (0591-2579-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/92281301-5fb5-4eea-8766-4863e241c234NADAC price for package 00591257920
GET /v1/drugs/nadac/00591257920
Use it
Look up 0591-2579 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2579 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-2579. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.